Below is an overview of the development and science behind . TRG-035: The World's First Tooth Regrowth Drug
If clinical trials continue to show success, researchers aim to make TRG-035 commercially available by . This would offer a biological alternative to traditional prosthetic solutions like dental implants, bridges, or dentures. Japan Begins Human Trials for Tooth Regrowth Drug TRG-035 NEWM-035
: The drug targets a specific protein called USAG-1 (uterine sensitization-associated gene-1). In nature, USAG-1 acts as a "biological parking brake" that prevents dormant tooth buds in the human jaw from developing into full teeth after the adult set has grown. Below is an overview of the development and science behind
The drug was developed by , a spinoff from Kyoto University, led by Dr. Katsu Takahashi. a spinoff from Kyoto University